Although rotational atherectomy (RA) is used for complex lesions in percutaneous coronary intervention, there are several contraindications and precautions. The purpose of our study was to compare complications between off-label…
Patients with previously implanted coronary stents are at risk for stent thrombosis if dual-antiplatelet therapy is prematurely discontinued. Bridging with a glycoprotein IIb/IIIa inhibitor has been advocated as an alternative,…
Bivalirudin, a direct thrombin inhibitor, is as effective as unfractionated heparin (UFH), with decreased bleeding in patients with acute coronary syndromes who undergo percutaneous coronary intervention (PCI). The aim of…
Previous angiographic studies have suggested that the future risk for major adverse cardiovascular events (MACEs) is related to coronary stenosis severity. The aim of this study was to use the…
Peter Libby was born in Berkeley, California, on February 13, 1947, and grew up in that city as well. He graduated in 1969 from the University of California (UC), Berkeley…
The prevalence of coronary artery disease (CAD) in patients with peripheral arterial disease (PAD) varies widely in published reports. This is likely due at least in part to significant differences…
The wording in the fourth sentence of the second column on the second page of the article was incorrect. The sentence should have read: “Late HR recovery at 5 minutes…
In 2006, I reported my experience with chronic and advanced heart failure, which occurred in 2003. The memory of my hospitalization from years ago had begun to fade until my…
Ho et al reported that improved renal function associated with high-dose atorvastatin reduced hospitalization for heart failure (HF) in the Treating to New Targets (TNT) trial. In the Greek Atorvastatin…
Risk estimates are based on information from the general population, and the accuracy of these models has not been adequately evaluated in patients with rheumatoid arthritis (RA). In their report,…
